NxStage Medical, Inc.NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...

Please provide your email address to receive an email when new articles are posted on . The U.S. Food and Drug Administration has cleared NxStage Medical Inc.'s System One to perform home nocturnal ...

NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, ...

LAWRENCE, Mass., Aug. 4, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, joins over one hundred NxStage patients in ...

Please provide your email address to receive an email when new articles are posted on . NxStage Medical Inc.’s next generation System One hemodialysis system has received the CE mark in Europe. The ...

Home healthcare is a buzzphrase these days, and with good justification, including the aging population and a growing focus on cost-cutting within the healthcare system. Medical device companies are ...

NxStage Medical, Inc.NXTM recently announced the receipt of CE mark for its NxGen Hemodialysis System, an innovative device with easier user interface and integrated blood pressure monitor system for ...

LAWRENCE, Mass., Oct. 18, 2018 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, announced new findings demonstrating ...

Home dialysis specialist NxStage Medical (NXTM +0.00%) has made a huge change in how patients get the treatment they need, offering an alternative to the outpatient services that Fresenius Medical ...

NxStage Medical (NASDAQ: NXTM) has revolutionized the way that dialysis patients receive treatment, with its home-dialysis devices offering a much more convenient alternative to visiting outpatient ...